---
figid: PMC3291787__nihms-349732-f0004
figtitle: Targeting the EGFR signaling pathway in cancer therapy
organisms:
- Mus musculus
- Rattus norvegicus
- Glycine max
- Diaporthe sclerotioides
- Homo sapiens
organisms_ner:
- Mus musculus
pmcid: PMC3291787
filename: nihms-349732-f0004.jpg
figlink: /pmc/articles/PMC3291787/figure/F4/
number: F3
caption: (1) Therapeutic invention site for EGFR specific monoclonal antibodies (Cetuximab
  and Panitumumab), (2) Potential target for small molecule tyrosine kinase inhibitors
  (Gifitinib, Erlotinib, Lapatinib and Canertinib), (3) Synergistic role of chemopreventive
  agents (Genistein, Curcumin and Caspacin).
papertitle: Targeting the EGFR signaling pathway in cancer therapy.
reftext: Parthasarathy Seshacharyulu, et al. Expert Opin Ther Targets. ;16(1):15-31.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9197955
figid_alias: PMC3291787__F3
figtype: Figure
redirect_from: /figures/PMC3291787__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3291787__nihms-349732-f0004.html
  '@type': Dataset
  description: (1) Therapeutic invention site for EGFR specific monoclonal antibodies
    (Cetuximab and Panitumumab), (2) Potential target for small molecule tyrosine
    kinase inhibitors (Gifitinib, Erlotinib, Lapatinib and Canertinib), (3) Synergistic
    role of chemopreventive agents (Genistein, Curcumin and Caspacin).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egfr
  - Tk2
  - tk
  - Canertinib
  - Curcumin
---
